Common Contracts

BIOSANTE PHARMACEUTICALS, INC. SECURITIES EXCHANGE AGREEMENT FEBRUARY 15, 2012

Securities Exchange Agreement • May 8th, 2012 • Biosante Pharmaceuticals Inc • Biological products, (no disgnostic substances) • New York

• Contract Type
  Securities Exchange Agreement
• Filed
  May 8th, 2012
• Company
  Biosante Pharmaceuticals Inc
• Industry
  Biological products, (no disgnostic substances)
• Jurisdiction
  New York

This Securities Exchange Agreement (this “Agreement”) is made as of February 15, 2012 (the “Effective Date”) by and between BIOSANTE PHARMACEUTICALS, INC., a Delaware corporation (the “Company”), and TANG CAPITAL PARTNERS, LP, a Delaware limited partnership (the “Bond Holder”).

BIOSANTE PHARMACEUTICALS, INC. SECURITIES EXCHANGE AGREEMENT FEBRUARY 7, 2012

Securities Exchange Agreement • May 8th, 2012 • Biosante Pharmaceuticals Inc • Biological products, (no disgnostic substances) • New York

• Contract Type
  Securities Exchange Agreement
• Filed
  May 8th, 2012
• Company
  Biosante Pharmaceuticals Inc
• Industry
  Biological products, (no disgnostic substances)
• Jurisdiction
  New York

This Securities Exchange Agreement (this “Agreement”) is made as of February 7, 2012 (the “Effective Date”) by and between BIOSANTE PHARMACEUTICALS, INC., a Delaware corporation (the “Company”), and TANG CAPITAL PARTNERS, LP, a Delaware limited partnership (the “Bond Holder”).